Key facts
- It has raised $5.2M; the latest was Accelerator/Incubator ($2.9M) in Oct 2025.
- Notable investors include Invest-NL (Investment Company), InnovationQuarter, Delft Enterprises, Navus Holding, Broadview Holding — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for DAB.bio
- ·The full record, as it builds
Funding rounds
No funding rounds for DAB.bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DAB.bio
Developer of bioreactor technology designed to establish continuous and stable operations as the foundation of fermentation processes. The company offers a combined approach that unifies fermentation with continuous separation and extraction of products in a single vessel, enabling industrial producers to increase reactor output, improve feedstock yield, lower capital and operational expenditure, and enhance the environmental footprint of fermentative production.
- Sector
- Business Products and Services (B2B)
- HQ
- Delft, Netherlands
- Founded
- 2008
- Employees
- 20
- Website
- dab.bio/
- Ownership
- Privately Held (backing)
DAB.bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DAB.bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DAB.bio in its N-PORT filings yet. We sweep new filings monthly.